Skip to content
Sign In

Main Navigation

James Sharp Logo
  • Individuals
    Individuals

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service
  • Charities & Trustees
    Charities & Trustees

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service

  • Companies
    Companies

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service

  • News & Insights
    • News & Insights
    • Current Research Coverage List
  • About Us
    • About Us
    • Our People
  • Conectus Portal
  • Contact Us

Market News - Page 105

23 September 2024

AstraZeneca Announces Results for Datopotamab Deruxtecan

23 September 2024 Datopotamab deruxtecan final overall survival results reported in patients with metastatic HR-positive, HER2-low or negative breast cancer in TROPION-Breast01 Phase III…

18 September 2024

Murray Income Trust plc Annual Report 30th June 2024

Murray Income Trust PLC Annual Report 30 June 2024 Performance Highlights Net asset value total returnABC ​ Share price total returnAB +9.9% ​ +7.6%…

18 September 2024

Games Workshop plc Trading Update September 2024

 18 September 2024 Games Workshop Group PLC TRADING UPDATE Games Workshop Group PLC announces that trading for the three months to 1 September 2024…

18 September 2024

MJ Gleeson plc Audited Results for the Year Ended 30th June 2024

18 September 2024 MJ Gleeson plc (GLE.L) (“Gleeson” or “the Group” or “the Company”) Audited results for the year ended 30 June 2024 (“FY2024”)…

18 September 2024

Advanced Medical Solutions Group plc Interim Results for Six Months Ended June 2024

18 September 2024 Advanced Medical Solutions Group plc (“AMS” or the “Group”)   Interim results for the six months ended 30 June 2024 ~…

18 September 2024

PZ Cussons- Results for the Year Ended May 2024

18 September 2024 RESULTS FOR THE YEAR ENDED 31 MAY 2024 Progress on strategic priorities and portfolio transformation Continued business momentum despite macro-economic challenges…

18 September 2024

AstraZeneca plc Announces Fasenra EGPA FDA Approval

18 September 2024 Fasenra approved in the US for eosinophilic granulomatosis with polyangiitis New indication supported by the MANDARA trial which showed nearly 60% of…

17 September 2024

Euronext Acquires Substantive Research

Euronext acquires leading research and market data benchmarking provider Substantive Research Amsterdam, Brussels, Dublin, Lisbon, London, Milan, Oslo and Paris – 17 September 2024…

Posts navigation

  • «
  • 1
  • …
  • 103
  • 104
  • 105
  • 106
  • 107
  • …
  • 907
  • »

Home > Market News > Page 105

James Sharp white Logo
Sign In
Linkedin Icon

The Exchange
5 Bank Street
Bury, Lancashire
BL9 0DN

Tel: 0161 764 4043

Fax: 0161 764 1628

Email: mail@jamessharp.co.uk

Linkedin Icon

James Sharp & Co is a trading name
of James Sharp & Co LLP (0C422665)

Members of the LLP are referred to as Partners

  • Downloads & Resources
  • Complaints
  • Financial Compensation Scheme
  • Conectus Portal

  • Cyber Essentials Certification
  • Website Terms & Conditions
  • Privacy Policy
  • Cookie policy
  • Consent Preferences

Email Newsletter Sign-up

Consent(Required)
What we do with you information. Find out more

© Copyright 2010-2026. All rights reserved. James Sharp & Co. Authorised & Regulated by the Financial Conduct Authority
Member of the London Stock Exchange - Member of the Aquis Stock Exchange - Member of PIMFA

Website by ICG